Apnoea, neonatal

Note: Always assess gestational age as accurately as possible. See appendix: Ballard Scoring Assessment.


APNOEA, NEONATAL

P28.3


DESCRIPTION

A neonate presenting with episodes of cessation of breathing.

Apnoea episodes in a previously asymptomatic well neonate may be the first indication of a serious underlying disease.

Apnoea episodes in an already unwell neonate indicate deterioration in the condition of the neonate.

DIAGNOSTIC CRITERIA

  • Cessation of respiration for longer than 20 seconds, with/without cyanosis, pallor or bradycardia.
  • Cessation of respiration for less than 20 seconds with cyanosis, pallor and/or bradycardia.

Central apnoea

Causes include:

  • IRDS
  • prematurity
  • hypoxia/hypercarbia
  • sepsis
  • acidosis
  • meningitis
  • temperature disturbances
  • hypotension
  • pneumonia
  • intraventricular haemorrhage
  • patent ductus arteriosus
  • hypoglycaemia
  • hypermagnesaemia
  • atypical convulsions
  • anaemia
  • rough or excessive handling
  • medicines (sedatives, anticonvulsants, analgesics).

Obstructive apnoea

Neonates are obligatory “nose breathers”. Obstruction of the nares make neonates prone to apnoea.

Causes of obstructive apnoea include:

  • choanal atresia,
  • gastro-oesophageal reflux,
  • micrognathia,
  • macroglossia,
  • secretions (milk, meconium, blood, mucus) lodged in the upper airway, and
  • neck flexion or extension.

Reflex apnoea or vagally mediated apnoea

Is due to:

  • endotracheal intubation,
  • passage of a nasogastric tube,
  • gastro-oesophageal reflux,
  • overfeeding, and
  • suction of the pharynx or stomach.

Mixed apnoea

Apnoea caused by a combination of the above causes.

GENERAL AND SUPPORTIVE MEASURES

For all forms of neonatal apnoea:

  • Identify and treat the underlying cause.
  • Frequent gentle physical stimulation e.g. rubbing of soles of feet.
  • Nurse preterm neonates in the prone position.
  • Maintain ambient temperature at the lower range of neutral thermal environment.
  • Maintain axillary temperature or anterior abdominal wall temperature at 36.2–36.8°C.
  • Maintain haematocrit at 40%.
  • Maintain nasal CPAP of 4 cm water. (Nasal CPAP – not for central apnoea except for apnoea of prematurity.)
  • Monitor vital signs and parameters relating to the underlying cause.

MEDICINE TREATMENT

To maintain oxygen/haemoglobin saturation of 90-94% or an oxygen tension in the blood at 60–80 mmHg:

  • Oxygen via nasal cannula, headbox, or mask.

Only for apnoea of prematurity (not term infants):

  • Caffeine base, (anhydrous), oral/IV (dose expressed as caffeine base)
    • Loading dose: 10–12.5 mg/kg.
    • Maintenance dose: 2.5–5 mg/kg/24 hours. Start maintenance dose 24 hours after the loading dose.
      (Caffeine citrate 20mg = caffeine base 10 mg)

OR

  • Aminophyline, IV/oral.
    • Loading dose: 8 mg/kg. (If IV infusion, administer over 30 minutes).
    • Maintenance dose: 1.5–3 mg/kg/dose 8 hourly. Start maintenance dose 8 hours after loading dose.

Maintain aminophylline blood levels at 10–12 mcg/mL.

If neonate responds favourably to caffeine/aminophyline continue until neonate is apnoea free for 7 days.

REFERRAL

  • Recurrent life-threatening episodes of apnoea, not responding to adequate treatment and requiring ventilation.